Free Trial

Target Healthcare REIT (THRL) Competitors

Target Healthcare REIT logo
GBX 100.20 -1.00 (-0.99%)
As of 11:51 AM Eastern

THRL vs. AGR, PHP, IHR, LABS, MXF, DLN, IWG, GPOR, BYG, and LXI

Should you be buying Target Healthcare REIT stock or one of its competitors? The main competitors of Target Healthcare REIT include Assura (AGR), Primary Health Properties (PHP), Impact Healthcare REIT (IHR), Life Science REIT (LABS), Medicx Fund (MXF), Derwent London (DLN), IWG (IWG), Great Portland Estates (GPOR), Big Yellow Group (BYG), and Lxi Reit (LXI). These companies are all part of the "real estate" sector.

Target Healthcare REIT vs. Its Competitors

Assura (LON:AGR) and Target Healthcare REIT (LON:THRL) are both small-cap real estate companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, risk, dividends, institutional ownership, media sentiment and profitability.

Target Healthcare REIT has a net margin of 104.99% compared to Assura's net margin of -18.09%. Target Healthcare REIT's return on equity of 10.78% beat Assura's return on equity.

Company Net Margins Return on Equity Return on Assets
Assura-18.09% -1.92% 2.82%
Target Healthcare REIT 104.99%10.78%3.86%

Assura currently has a consensus target price of GBX 51, suggesting a potential upside of 1.80%. Given Assura's stronger consensus rating and higher possible upside, equities research analysts plainly believe Assura is more favorable than Target Healthcare REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Assura
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Target Healthcare REIT
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Assura and Assura both had 1 articles in the media. Target Healthcare REIT's average media sentiment score of 1.11 beat Assura's score of 0.59 indicating that Target Healthcare REIT is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Assura
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Target Healthcare REIT
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Target Healthcare REIT has lower revenue, but higher earnings than Assura. Assura is trading at a lower price-to-earnings ratio than Target Healthcare REIT, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Assura£188.76M8.65-£34.15M-£1.05-47.89
Target Healthcare REIT£68.64M8.94£72.07M£11.938.40

Assura has a beta of 0.37, indicating that its stock price is 63% less volatile than the S&P 500. Comparatively, Target Healthcare REIT has a beta of 0.44, indicating that its stock price is 56% less volatile than the S&P 500.

Assura pays an annual dividend of GBX 3 per share and has a dividend yield of 6.0%. Target Healthcare REIT pays an annual dividend of GBX 6 per share and has a dividend yield of 6.0%. Assura pays out -286.8% of its earnings in the form of a dividend. Target Healthcare REIT pays out 50.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

73.7% of Assura shares are held by institutional investors. Comparatively, 69.4% of Target Healthcare REIT shares are held by institutional investors. 8.4% of Assura shares are held by company insiders. Comparatively, 0.1% of Target Healthcare REIT shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Target Healthcare REIT beats Assura on 9 of the 16 factors compared between the two stocks.

Get Target Healthcare REIT News Delivered to You Automatically

Sign up to receive the latest news and ratings for THRL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding THRL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

THRL vs. The Competition

MetricTarget Healthcare REITREIT IndustryReal Estate SectorLON Exchange
Market Cap£613.33M£1.65B£1.61B£3.01B
Dividend Yield7.00%7.52%6.26%5.02%
P/E Ratio8.401.4010.38149.15
Price / Sales8.94541.821,457.80254,247.77
Price / Cash14.3749.2266.7927.97
Price / Book0.901.441.314.57
Net Income£72.07M-£74.43M-£120.13M£5.90B
7 Day Performance-1.96%-0.81%0.32%7.46%
1 Month Performance-1.38%2.62%1.69%11.33%
1 Year Performance22.49%17.52%12.66%81.12%

Target Healthcare REIT Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
THRL
Target Healthcare REIT
N/AGBX 100.20
-1.0%
N/A+27.0%£613.33M£68.64M8.40N/ANews Coverage
Positive News
AGR
Assura
1.12 of 5 stars
GBX 49.96
-0.3%
GBX 51
+2.1%
+19.2%£1.63B£188.76M-47.7684
PHP
Primary Health Properties
1.9378 of 5 stars
GBX 96.60
+0.1%
GBX 107.50
+11.3%
+4.8%£1.30B£178.59M-150.7958
IHR
Impact Healthcare REIT
N/AN/AN/AN/A£361.75M£53.51M793.64N/A
LABS
Life Science REIT
N/AGBX 43.85
-0.6%
GBX 46.50
+6.0%
+27.5%£155.68M£20.41M-3.89N/A
MXF
Medicx Fund
N/AN/AN/AN/A£0.00N/A0.00N/AHigh Trading Volume
DLN
Derwent London
2.822 of 5 stars
GBX 1,977
flat
GBX 2,700
+36.6%
-12.2%£2.21B£277.67M-6.13199
IWG
IWG
2.3017 of 5 stars
GBX 214.80
-0.5%
GBX 270
+25.7%
+25.0%£2.16B£2.76B-15.9710,000
GPOR
Great Portland Estates
N/AN/AN/AN/A£1.87B£100.70M124.66210Positive News
Gap Up
BYG
Big Yellow Group
N/AGBX 952.08
+1.5%
N/A-18.9%£1.86B£200.54M7.71503News Coverage
Dividend Announcement
LXI
Lxi Reit
N/AN/AN/AN/A£1.72B£256.30M-458.18N/A

Related Companies and Tools


This page (LON:THRL) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners